Literature DB >> 31291186

Prostate MRI and transperineal TRUS/MRI fusion biopsy for prostate cancer detection: clinical practice updates.

Eugenio Martorana1, Giacomo Maria Pirola2, Maria Cristina Aisa3, Pietro Scialpi4, Aldo Di Blasi5, Giovanni Saredi6, Alfredo D'Andrea7, Stefano Signore8, Riccardo Grisanti1, Michele Scialpi9.   

Abstract

This narrative review summarizes the current knowledge about multiparametric and biparametric magnetic resonance imaging of the prostate. This is provided from both a radiological and a urological point of view analyzing the technical aspects of fusion-targeted biopsy using the transperineal approach. We report practical considerations concerning pure cognitive and software-assisted settings, discuss the principal transperineal fusion software now available, and debate the pros and cons of choosing one approach over the other.

Entities:  

Year:  2019        PMID： 31291186      PMCID： PMC6619838          DOI： 10.5152/tud.2019.19106

Source DB:  PubMed          Journal:  Turk J Urol        ISSN： 2149-3235


  42 in total

1.  MR imaging-guided prostate biopsy with surgical navigation software: device validation and feasibility.

Authors:  N Hata; M Jinzaki; D Kacher; R Cormak; D Gering; A Nabavi; S G Silverman; A V D'Amico; R Kikinis; F A Jolesz; C M Tempany
Journal:  Radiology       Date:  2001-07       Impact factor: 11.105

2.  Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.

Authors:  M Noguchi; T A Stamey; J E McNeal; C M Yemoto
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

3.  Transperineal ultrasound-guided saturation biopsies using 11-region template of prostate: report of 303 cases.

Authors:  Hanzhong Li; Weigang Yan; Yi Zhou; Zhigang Ji; Jie Chen
Journal:  Urology       Date:  2007-12       Impact factor: 2.649

4.  Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy.

Authors:  Deepak Batura; G Gopal Rao; Peder Bo Nielsen
Journal:  BJU Int       Date:  2010-03-16       Impact factor: 5.588

5.  Complications after prostate biopsy: data from SEER-Medicare.

Authors:  Stacy Loeb; H Ballentine Carter; Sonja I Berndt; Winnie Ricker; Edward M Schaeffer
Journal:  J Urol       Date:  2011-09-23       Impact factor: 7.450

6.  Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy.

Authors:  Alessandro Sciarra; Valeria Panebianco; Mauro Ciccariello; Stefano Salciccia; Susanna Cattarino; Danilo Lisi; Alessandro Gentilucci; Andrea Alfarone; Silvia Bernardo; Roberto Passariello; Vincenzo Gentile
Journal:  Clin Cancer Res       Date:  2010-03-02       Impact factor: 12.531

7.  Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment.

Authors:  Mark S Soloway; Cynthia T Soloway; Ahmed Eldefrawy; Kristell Acosta; Bruce Kava; Murugesan Manoharan
Journal:  Eur Urol       Date:  2010-08-20       Impact factor: 20.096

8.  Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six-core prostate biopsy.

Authors:  P Emiliozzi; A Corsetti; B Tassi; G Federico; M Martini; V Pansadoro
Journal:  Urology       Date:  2003-05       Impact factor: 2.649

9.  Bacterial sepsis after prostate biopsy--a new perspective.

Authors:  Dirk Lange; Christopher Zappavigna; Reza Hamidizadeh; S Larry Goldenberg; Ryan F Paterson; Ben H Chew
Journal:  Urology       Date:  2009-10-07       Impact factor: 2.649

Review 10.  Optimal biopsy strategies for the diagnosis and staging of prostate cancer.

Authors:  Amit R Patel; J Stephen Jones
Journal:  Curr Opin Urol       Date:  2009-05       Impact factor: 2.309
View more
  4 in total

Review 1.  Developments in optimizing transperineal prostate biopsy.

Authors:  Emily Cheng; Meenakshi Davuluri; Patrick J Lewicki; Jim C Hu; Spyridon P Basourakos
Journal:  Curr Opin Urol       Date:  2022-01-01       Impact factor: 2.808

2.  The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate Cancer.

Authors:  Marcin Miszczyk; Justyna Rembak-Szynkiewicz; Łukasz Magrowski; Konrad Stawiski; Agnieszka Namysł-Kaletka; Aleksandra Napieralska; Małgorzata Kraszkiewicz; Grzegorz Woźniak; Małgorzata Stąpór-Fudzińska; Grzegorz Głowacki; Benjamin Pradere; Ekaterina Laukhtina; Paweł Rajwa; Wojciech Majewski
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

3.  Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study.

Authors:  Giacomo M Pirola; Marilena Gubbiotti; Emanuele Rubilotta; Daniele Castellani; Nicolò Trabacchin; Alessandro Tafuri; Alessandro Princiotta; Eugenio Martorana; Filippo Annino; Alessandro Antonelli
Journal:  Prostate Int       Date:  2021-12-07

4.  Software-assisted US/MRI fusion-targeted biopsy for prostate cancer.

Authors:  Salvatore Alessio Angileri; Letizia Di Meglio; Mario Petrillo; Antonio Arrichiello; Marco Pandolfi; Giovanni Maria Rodà; Giuseppe Granata; Anna Maria Ierardi; Daniela Donat; Aldo Paolucci; Gianpaolo Carrafiello
Journal:  Acta Biomed       Date:  2020-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.